Cartesian Therapeutics (RNAC) EBITDA Margin Growth (5y) (2020 - 2026)
Cartesian Therapeutics (RNAC) EBITDA Margin Growth (5y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Cartesian Therapeutics | 211.08 Mn | 211.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.39 Mn |
| Dec 31, 2025 | -823,793.00 |
| Dec 31, 2024 | 338,640.00 |
| Jun 30, 2024 | 12.49 Mn |
| Mar 31, 2024 | 11.83 Mn |
| Dec 31, 2023 | 116,611.00 |
| Dec 31, 2022 | 11.33 Mn |
| Sep 30, 2022 | 5.13 Mn |
| Jun 30, 2022 | 6.11 Mn |
| Mar 31, 2022 | 1.08 Mn |
| Dec 31, 2021 | 48,666.00 |
| Sep 30, 2021 | 70,453.00 |
| Jun 30, 2021 | 31,965.00 |
| Mar 31, 2021 | 26,765.00 |
| Dec 31, 2020 | 26,695.00 |
| Sep 30, 2020 | 8,218.00 |